Quantitative analysis of bronchial wall vascularity in the medium and small airways of patients with asthma and COPD

Chest

Volumn 127, Issue 3, 2005, Pages 965-972

  Hashimoto, Midori ^a   Tanaka, Hiroshi ^a   Abe, Shosaku ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Airway remodeling; Angiogenesis; Asthma; COPD; Vascular endothelial growth factor

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; CD31 ANTIGEN; CD34 ANTIGEN; VASCULOTROPIN; FIBROBLAST GROWTH FACTOR 2; VASCULOTROPIN A;

ADULT; AGED; AIRWAY; ANGIOGENESIS; ARTICLE; ASTHMA; BRONCHUS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG BLOOD VESSEL; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RESPIRATORY AIRFLOW; CHEMISTRY; METABOLISM; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM; VASCULARIZATION;

AGED; ANTIGENS, CD31; ANTIGENS, CD34; ASTHMA; BRONCHI; ENDOTHELIUM, VASCULAR; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 15844401603     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.127.3.965     Document Type: Article

References (26)

1. Bousquet J, Jeffery PK, Busse WW, et al. Asthma: from bronchoconstriction to airway inflammation and remodeling. Am J Respir Grit Care Med 2000; 161:1720-1745
2. Beckett PA, Howarth PH. Pharmacotherapy and airway remodeling in asthma? Thorax 2003; 58:163-174
3. Hogg JC, Pare PD, Moreno R. The effect of submucosal edema on airways resistance. Am Rev Respir Dis 1987; 135:354-356
4. Hamid Q, Song Y, Kotsimbos TC, et al. Inflammation of the small airways in asthma. J Allergy Clin Immunol 1997; 100:44-51
5. Li X, Wilson JW. Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med 1997; 156:229-233
6. Vrugt B, Wilson S, Bron A, et al. Bronchial angiogenesis in severe glucocorticosteroid-dependent asthma. Eur Respir J 2000; 15:1014-1021
7. Chetta A, Zanini A, Foresi A, et al. Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone. Am J Respir Crit Care Med 2003; 167:751-757
8. Salvato G. Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects. Thorax 2001; 56:902-906
9. Kuwano K, Bosken CH, Pare PD, et al. The small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1993; 148:1220-1225
10. Carroll N, Cooke C, James A. Bronchial blood vessel dimensions in asthma. Am J Respir Crit Care Med 1997; 155:689-695
11. Bosken CH, Wiggs BR, Pare PD, et al. Small airway dimensions in smokers with obstruction to airflow. Am Rev Respir Dis 1990; 142:563-570
12. Folkman J. Seminars in medicine of the Beth Israel Hospital, Boston: clinical applications of research on angiogenesis. N Engl J Med 1995; 333:1757-1763
13. Demoly P, Maly FE, Mautino G, et al. VEGF levels in asthmatic airways do not correlate with plasma extravasation. Clin Exp Allergy 1999; 29:1390-1394
14. Hoshino M, Takahashi M, Aoike N. Expression of vascular endothelial growth factors, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 2001; 107:295-301
15. Asai K, Kanazawa H, Otani K, et al. Imbalance between vascular endothelial growth factor and endostatin levels in induced sputum from asthmatic subjects. J Allergy Clin Immunol 2002; 110:571-575
16. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136:225-244
17. National Institutes of Health, National Heart Lung, and Blood Institute. Global strategy for asthma management and prevention: revised 2002. Bethesda, MD: National Institutes of Health, National Heart Lung, and Blood Institute; NIH publication No. 02-3659
18. Pauwels RA, Buist AS, Calverley PMA, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Grit Care Med 2001; 163:1256-1276
19. Balzar S, Wenzel SE, Chu HW. Transbronchial biopsy as a tool to evaluate the small airways in asthma. Eur Respir J 2002; 20:254-259
20. Carroll N, Cooke C, James A. The distribution of eosinophils and lymphocytes in the large and the small airways of asthmatics. Eur Respir J 1997; 10:292-300
21. Weibel ER. Morphometry of the human lung. Berlin, Germany: Springer-Verlag, 1963
22. Kanazawa H, Asai K, Hirata K, et al. Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. Am J Med 2003; 114:354-358
23. Tanaka H, Yamada G, Saikai T, et al. Increased airway vascularity in newly diagnosed asthma using a high-magnification bronchovideoscope. Am J Respir Grit Care Med 2003; 168:1495-1499
24. Hoshino M, Takahashi M, Takai Y, et al. Inhaled corticosteroid decrease vascularity of the bronchial mucosa in patients with asthma. Clin Exp Allergy 2001; 31:722-730
25. Orsida BE, Ward C, Li X, et al. Effect of a long-acting β2-agonist over three months on airway wall vascular remodeling in asthma. Am J Respir Crit Care Med 2001; 164:117-121
26. Orsida BE, Li X, Hickey B, et al. Vascularity in asthmatic airways: relation to inhaled steroid dose. Thorax 1999; 54:289-295